(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are ATOS, ABIONYX PHARMA, and EQVA.

Financial Asset	Price	Change	Updated (EST)
ATOS (ATO.PA)	0.87	14.01%	2024-06-14 12:46:31
ABIONYX PHARMA (ABNX.PA)	1.39	11.16%	2024-06-14 12:45:15
EQVA (EQVA.OL)	5.10	6.92%	2024-06-14 12:26:29
MOTORK (MTRK.AS)	5.98	6.41%	2024-06-14 12:03:13
VISTIN PHARMA (VISTN.OL)	23.80	6.25%	2024-06-14 12:44:44
AKASTOR (AKAST.OL)	16.38	5.95%	2024-06-14 12:24:46
MOURY CONSTRUCT (MOUR.BR)	585.00	5.41%	2024-06-14 12:20:52
ALTRI SGPS (ALTR.LS)	5.26	5.2%	2024-06-14 12:23:01
NAPATECH (NAPA.OL)	37.40	5.06%	2024-06-14 12:41:23
KMC PROPERTIES (KMCP.OL)	7.38	4.24%	2024-06-14 12:40:56

The three biggest losers today are UNIFIEDPOST GROUP, AFFLUENT MEDICAL, and PCI BIOTECH HOLD.

Financial Asset	Price	Change	Updated (EST)
UNIFIEDPOST GROUP (UPG.BR)	2.60	-11.82%	2024-06-14 12:21:57
AFFLUENT MEDICAL (AFME.PA)	1.60	-8.31%	2024-06-14 12:45:44
PCI BIOTECH HOLD (PCIB.OL)	1.94	-7.65%	2024-06-14 12:42:15
AB SCIENCE (AB.PA)	1.10	-7.42%	2024-06-14 12:45:09
POLIGHT (PLT.OL)	3.85	-7%	2024-06-14 12:42:28
PROSAFE (PRS.OL)	35.45	-6.71%	2024-06-14 12:42:30
KENMARE RESOURCES (KMR.IR)	3.92	-6.67%	2024-06-14 12:22:48
ASSYSTEM (ASY.PA)	55.00	-6.46%	2024-06-14 12:46:26
GAMING INNOVATION (GIG.OL)	29.15	-6.12%	2024-06-14 12:40:06
PETROLIA (PSE.OL)	5.05	-5.61%	2024-06-14 12:42:16

Winners today

1. ATOS (ATO.PA)

14.01% Price Change

Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, and telecommunication and media industries. The company was incorporated in 1982 and is headquartered in Bezons, France.

CAC 40 ended the session with ATOS jumping 14.01% to €0.87 on Friday, after five successive sessions in a row of losses. CAC 40 fell 2.66% to €7,503.27, following the last session’s downward trend on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, ATOS has a trailing twelve months EPS of €-31.04.

Volatility

ATOS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 17.08%, a negative 6.63%, and a positive 5.93%.

ATOS’s highest amplitude of average volatility was 17.08% (last week), 7.68% (last month), and 5.93% (last quarter).

More news about ATOS.

2. ABIONYX PHARMA (ABNX.PA)

11.16% Price Change

ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. It develops CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.

CAC 40 ended the session with ABIONYX PHARMA jumping 11.16% to €1.39 on Friday while CAC 40 dropped 2.66% to €7,503.27.

Earnings Per Share

As for profitability, ABIONYX PHARMA has a trailing twelve months EPS of €-0.12.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.11%.

Volatility

ABIONYX PHARMA’s last week, last month’s, and last quarter’s current intraday variation average was 2.54%, 0.67%, and 2.42%.

ABIONYX PHARMA’s highest amplitude of average volatility was 4.26% (last week), 3.45% (last month), and 2.42% (last quarter).

Volume

Today’s last reported volume for ABIONYX PHARMA is 458107 which is 728.34% above its average volume of 55304.

Revenue Growth

Year-on-year quarterly revenue growth declined by 19.1%, now sitting on 4.75M for the twelve trailing months.

Yearly Top and Bottom Value

ABIONYX PHARMA’s stock is valued at €1.39 at 22:40 EST, way below its 52-week high of €2.38 and way above its 52-week low of €1.05.

More news about ABIONYX PHARMA.

3. EQVA (EQVA.OL)

6.92% Price Change

Eqva ASA, provides technical solutions and services to maritime and land based industries in Norway and internationally. It operates in three segments: Products, Solutions & Renewables; Real Estate; and Other. The company provides technical installations to the land-based and maritime industry; and develops and operates small-scale hydropower plants. It also engages in real estate business. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was incorporated in 1999 and is headquartered in Kvinnherad, Norway.

Oslo Børs Benchmark Index_GI ended the session with EQVA jumping 6.92% to €5.10 on Friday while Oslo Børs Benchmark Index_GI fell 0.61% to €1,391.56.

Earnings Per Share

As for profitability, EQVA has a trailing twelve months EPS of kr0.23.

PE Ratio

EQVA has a trailing twelve months price to earnings ratio of 22.17. Meaning, the purchaser of the share is investing kr22.17 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.45%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EQVA’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

EQVA’s stock is valued at kr5.10 at 22:40 EST, way above its 52-week high of kr4.00.

Volatility

EQVA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.29%, a positive 1.58%, and a positive 2.61%.

EQVA’s highest amplitude of average volatility was 2.29% (last week), 3.77% (last month), and 2.61% (last quarter).

More news about EQVA.

4. MOTORK (MTRK.AS)

6.41% Price Change

MotorK plc, together with its subsidiaries, provides software-as-a-service for the automotive retail industry in Italy, Spain, France, Germany, and the Benelux Union. The company offers a combination of automotive SaaS products and digital solutions to the digital lead generation, management, and nurturing process; and technology and software solutions for car manufacturers, dealers, and service centers. The company also provides WebSparK, a web platform for traffic acquisition and lead generation performance; LeadSparK, a CRM platform to support the activities of car dealerships and automotive manufacturers; and StockSparK, an automotive stock management platform. MotorK plc was incorporated in 2010 and is based in Milan, Italy.

AEX-Index ended the session with MOTORK jumping 6.41% to €5.98 on Friday while AEX-Index fell 0.64% to €918.72.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.36%.

More news about MOTORK.

5. VISTIN PHARMA (VISTN.OL)

6.25% Price Change

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with VISTIN PHARMA rising 6.25% to €23.80 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI fell 0.61% to €1,391.56, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.27.

PE Ratio

VISTIN PHARMA has a trailing twelve months price to earnings ratio of 18.74. Meaning, the purchaser of the share is investing kr18.74 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.84%.

Volume

Today’s last reported volume for VISTIN PHARMA is 2452 which is 91.68% below its average volume of 29479.

Moving Average

VISTIN PHARMA’s value is higher than its 50-day moving average of kr22.94 and above its 200-day moving average of kr22.98.

More news about VISTIN PHARMA.

6. AKASTOR (AKAST.OL)

5.95% Price Change

Akastor ASA operates as an oilfield services investment company in Norway and internationally. The company offers vessel-based subsea well construction and intervention services to the oil and gas industry. It also provides anchor handling, towing, and supply services to offshore oil and gas fields. In addition, the company offers a range of offshore drilling equipment products and packages. It owns offshore vessels and anchor handling tug supply vessels. Akastor ASA was founded in 1841 and is based in Bærum, Norway.

Oslo Børs Benchmark Index_GI ended the session with AKASTOR rising 5.95% to €16.38 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI slid 0.61% to €1,391.56, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, AKASTOR has a trailing twelve months EPS of kr0.9.

PE Ratio

AKASTOR has a trailing twelve months price to earnings ratio of 18.2. Meaning, the purchaser of the share is investing kr18.2 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.13%.

More news about AKASTOR.

7. MOURY CONSTRUCT (MOUR.BR)

5.41% Price Change

Moury Construct SA engages in the construction and renovation of residential and non-residential buildings for private and public markets in Belgium. The company constructs public and private buildings, commercial areas, halls of structures, renovation and restoration, and industries and services projects. It is also involved in the general carpentry, thermal, and acoustic insulations; prefabrication of concrete elements; and promotion and real estate arrangements. Moury Construct SA was founded in 1920 and is based in Liège, Belgium.

BEL 20 ended the session with MOURY CONSTRUCT rising 5.41% to €585.00 on Friday, after four consecutive sessions in a row of losses. BEL 20 fell 0.92% to €3,833.37, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, MOURY CONSTRUCT has a trailing twelve months EPS of €61.55.

PE Ratio

MOURY CONSTRUCT has a trailing twelve months price to earnings ratio of 9.5. Meaning, the purchaser of the share is investing €9.5 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.91%.

Yearly Top and Bottom Value

MOURY CONSTRUCT’s stock is valued at €585.00 at 22:40 EST, below its 52-week high of €640.00 and way higher than its 52-week low of €340.00.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MOURY CONSTRUCT’s stock is considered to be overbought (>=80).

More news about MOURY CONSTRUCT.

8. ALTRI SGPS (ALTR.LS)

5.2% Price Change

Altri, SGPS, S.A. produces and sells cellulosic fibers and energy in Portugal and internationally. The company produces pulp products for various application including production of paper, tissue, and printing and writing papers; and dissolving pulp for use of textile production. It is also involved timber commercialization; forest management; production of forest-based renewable energy, such as industrial cogeneration from black liquor and biomass; real estate activities; and production of plants in nurseries, as well as the provision of services related with forests and landscapes. The company was incorporated in 2005 and is headquartered in Porto, Portugal.

PSI ended the session with ALTRI SGPS rising 5.2% to €5.26 on Friday, following the last session’s downward trend. PSI fell 0.42% to €6,538.23, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, ALTRI SGPS has a trailing twelve months EPS of €0.22.

PE Ratio

ALTRI SGPS has a trailing twelve months price to earnings ratio of 23.91. Meaning, the purchaser of the share is investing €23.91 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.22%.

Sales Growth

ALTRI SGPS’s sales growth for the current quarter is negative 3.9%.

Moving Average

ALTRI SGPS’s value is higher than its 50-day moving average of €5.18 and way higher than its 200-day moving average of €4.69.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ALTRI SGPS’s stock is considered to be overbought (>=80).

Volatility

ALTRI SGPS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.58%, a negative 0.72%, and a positive 1.27%.

ALTRI SGPS’s highest amplitude of average volatility was 1.87% (last week), 1.47% (last month), and 1.27% (last quarter).

More news about ALTRI SGPS.

9. NAPATECH (NAPA.OL)

5.06% Price Change

Napatech A/S offers reconfigurable computing solutions for the networking and cybersecurity applications worldwide. The company provides Link Capture Software that enables packet capture with nanosecond timestamping and replay with precise inter-frame gap control; Link Inline Software, which offers a processing architecture that offloads and accelerates flow aware application data planes; Link Virtualization Software that offloads and accelerates the Open vSwitch data plane to enhance CPU efficiency and network performance; and Link Programmable, which enables end users and OEMs to deploy FPGA computation solutions. It offers solutions for telecom operators, cloud and data center service providers, and infrastructure and defense, as well as financial services, cyber security, network management, and virtualization. Napatech A/S was incorporated in 2003 and is based in Copenhagen, Denmark.

Oslo Børs Benchmark Index_GI ended the session with NAPATECH jumping 5.06% to €37.40 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI dropped 0.61% to €1,391.56, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, NAPATECH has a trailing twelve months EPS of kr-0.7.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.66%.

Moving Average

NAPATECH’s worth is way above its 50-day moving average of kr27.56 and way above its 200-day moving average of kr17.04.

Revenue Growth

Year-on-year quarterly revenue growth declined by 41.9%, now sitting on 167.12M for the twelve trailing months.

Yearly Top and Bottom Value

NAPATECH’s stock is valued at kr37.40 at 22:40 EST, under its 52-week high of kr38.00 and way above its 52-week low of kr8.70.

Volume

Today’s last reported volume for NAPATECH is 272377 which is 25.39% below its average volume of 365101.

More news about NAPATECH.

10. KMC PROPERTIES (KMCP.OL)

4.24% Price Change

KMC Properties ASA, a real estate company, owns and operates industrial and logistics properties. The company owns properties in the Nordics and the Netherlands in Moscow, Russia. KMC Properties ASA was incorporated in 2007 and is headquartered in Trondheim, Norway.

Oslo Børs Benchmark Index_GI ended the session with KMC PROPERTIES rising 4.24% to €7.38 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI dropped 0.61% to €1,391.56, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, KMC PROPERTIES has a trailing twelve months EPS of kr-0.09.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.7%.

Moving Average

KMC PROPERTIES’s value is higher than its 50-day moving average of kr7.34 and way higher than its 200-day moving average of kr6.38.

Volume

Today’s last reported volume for KMC PROPERTIES is 186273 which is 309.6% above its average volume of 45476.

Revenue Growth

Year-on-year quarterly revenue growth grew by 20.2%, now sitting on 428.7M for the twelve trailing months.

More news about KMC PROPERTIES.

Losers Today

1. UNIFIEDPOST GROUP (UPG.BR)

-11.82% Price Change

UnifiedPost Group SA, a fintech company, operates and develops a cloud-based platform for administrative and financial services in Belgium and internationally. Its platform allows connections between its customers, suppliers, customers, and other parties in the financial supply chain. The company offers a technology portfolio for document processing, identity management, payment services, and added value financial services, as well as engages in post and parcel optimization activities. It serves corporate and government customers; small and medium-sized enterprises; and agricultural, accounting, interim, and construction sectors. UnifiedPost Group SA was founded in 2001 and is headquartered in La Hulpe, Belgium.

BEL 20 ended the session with UNIFIEDPOST GROUP falling 11.82% to €2.60 on Friday while BEL 20 fell 0.92% to €3,833.37.

Earnings Per Share

As for profitability, UNIFIEDPOST GROUP has a trailing twelve months EPS of €-2.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -71%.

Moving Average

UNIFIEDPOST GROUP’s value is way below its 50-day moving average of €3.84 and way below its 200-day moving average of €3.01.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.1%, now sitting on 191.38M for the twelve trailing months.

More news about UNIFIEDPOST GROUP.

2. AFFLUENT MEDICAL (AFME.PA)

-8.31% Price Change

Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France.

CAC 40 ended the session with AFFLUENT MEDICAL sliding 8.31% to €1.60 on Friday while CAC 40 dropped 2.66% to €7,503.27.

Earnings Per Share

As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.54.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.37%.

Volatility

AFFLUENT MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.38%, a negative 0.06%, and a positive 1.93%.

AFFLUENT MEDICAL’s highest amplitude of average volatility was 0.57% (last week), 1.49% (last month), and 1.93% (last quarter).

Volume

Today’s last reported volume for AFFLUENT MEDICAL is 5950 which is 28.87% above its average volume of 4617.

Moving Average

AFFLUENT MEDICAL’s worth is way higher than its 50-day moving average of €1.31 and way above its 200-day moving average of €1.23.

Yearly Top and Bottom Value

AFFLUENT MEDICAL’s stock is valued at €1.60 at 22:40 EST, way below its 52-week high of €2.30 and way above its 52-week low of €0.93.

More news about AFFLUENT MEDICAL.

3. PCI BIOTECH HOLD (PCIB.OL)

-7.65% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company's technology platform consists of a proprietary small molecule photosensitiser (fimaporfin) and a light source; and develops photochemical internalisation (PCI), inducing light-triggered intracellular release for various therapeutic modalities, as well as photochemical lysis (PCL) comprising light-triggered cell lysis, which enhances yield and purity in viral vector manufacturing. It also explores for intratumoural immunotherapy therapeutics that identifies novel treatment combinations to overcome resistance to immune-checkpoint inhibitors and safety-issues associated with treatments; and develops nucleic acid therapeutics to improve the treatment of dermatological diseases. In addition, the company develops fimaVACC for immunotherapy indications, which is in pre-clinical study; fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study for bioprocessing and dermatology indications; and technology for viral vector manufacturing and pre-clinical research for intratumoural immunotherapy. PCI Biotech Holding ASA was incorporated in 2007 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD dropping 7.65% to €1.94 on Friday, after three consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI fell 0.61% to €1,391.56, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.54.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.

Moving Average

PCI BIOTECH HOLD’s value is way higher than its 50-day moving average of kr1.76 and higher than its 200-day moving average of kr1.91.

More news about PCI BIOTECH HOLD.

4. AB SCIENCE (AB.PA)

-7.42% Price Change

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

CAC 40 ended the session with AB SCIENCE falling 7.42% to €1.10 on Friday while CAC 40 slid 2.66% to €7,503.27.

Earnings Per Share

As for profitability, AB SCIENCE has a trailing twelve months EPS of €-0.2.

Moving Average

AB SCIENCE’s worth is way under its 50-day moving average of €3.07 and way under its 200-day moving average of €3.16.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AB SCIENCE’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth declined by 28.8%, now sitting on 777k for the twelve trailing months.

Yearly Top and Bottom Value

AB SCIENCE’s stock is valued at €1.10 at 22:40 EST, way below its 52-week low of €1.55.

More news about AB SCIENCE.

5. POLIGHT (PLT.OL)

-7% Price Change

poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; driver ASIC is designed to drive capacitive loads such as the TLens autofocus actuators; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. It serves smartphones and wearables, industrial, augmented reality, healthcare, and webcams markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLIGHT falling 7% to €3.85 on Friday, after two sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI dropped 0.61% to €1,391.56, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.19.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.82%.

Moving Average

POLIGHT’s worth is way above its 50-day moving average of kr2.98 and way below its 200-day moving average of kr11.09.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, POLIGHT’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 22.51M for the twelve trailing months.

Volume

Today’s last reported volume for POLIGHT is 2871230 which is 73.31% above its average volume of 1656660.

More news about POLIGHT.

6. PROSAFE (PRS.OL)

-6.71% Price Change

Prosafe SE, together with its subsidiaries, owns and operates semi-submersible accommodation vessels in South America, north America, and Europe. It is also involved in the maintenance and modification of installations on fields for the production, hook-up and commissioning of new fields, tiebacks to existing infrastructure, and decommissioning activities. The company owns and operates a fleet of six semi-submersible accommodation vessels and one tender support vessel. It primarily serves oil and gas industries. Prosafe SE was founded in 1972 and is headquartered in Stavanger, Norway.

Oslo Børs Benchmark Index_GI ended the session with PROSAFE sliding 6.71% to €35.45 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI dropped 0.61% to €1,391.56, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, PROSAFE has a trailing twelve months EPS of kr-42.91.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -261.72%.

More news about PROSAFE.

7. KENMARE RESOURCES (KMR.IR)

-6.67% Price Change

Kenmare Resources plc, together with its subsidiaries, engages in the production and sale of mineral sand products in China, the rest of Asia, Europe, the United States, and internationally. It operates the Moma Titanium Minerals Mine located on the northeast coast of Mozambique. The company's products include ilmenite, rutile, and zircon; monazite; and concentrates, including secondary zircon and mineral sand concentrates. It has a total proved and probable ore reserves of 1,429 million tons. The company was formerly known as Kenmare Oil Exploration plc and changed its name to Kenmare Resources plc in 1987. Kenmare Resources plc was incorporated in 1972 and is headquartered in Dublin, Ireland.

ISEQ All Share ended the session with KENMARE RESOURCES sliding 6.67% to €3.92 on Friday while ISEQ All Share slid 1.72% to €9,386.26.

Earnings Per Share

As for profitability, KENMARE RESOURCES has a trailing twelve months EPS of €1.27.

PE Ratio

KENMARE RESOURCES has a trailing twelve months price to earnings ratio of 3.09. Meaning, the purchaser of the share is investing €3.09 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.66%.

More news about KENMARE RESOURCES.

8. ASSYSTEM (ASY.PA)

-6.46% Price Change

Assystem S.A. provides engineering and infrastructure project management services worldwide. It provides engineering services for the preparation, design, and construction of critical and complex infrastructure projects for public authorities and utility companies. The company also offers engineering, procurement, and construction management; project management consulting; field operation management; siting, licensing, and environmental; systems engineering and design; industrial control system; and compliance, risk monitoring, safety, and security services, as well as digital transformation consulting, integrating business information system, data as a source of value, and digital twin services for nuclear, hydrogen, renewable, grids, transportation, cities and territorial development, and defense and security infrastructure sectors. In addition, it provides decommissioning and waste management services, and operation and maintenance services. The company was formerly known as AssystemBrime S.A. and changed its name to Assystem S.A. in June 2005. The company was founded in 1966 and is based in Courbevoie, France. Assystem S.A. is a subsidiary of HDL Development.

CAC 40 ended the session with ASSYSTEM falling 6.46% to €55.00 on Friday while CAC 40 slid 2.66% to €7,503.27.

Earnings Per Share

As for profitability, ASSYSTEM has a trailing twelve months EPS of €6.79.

PE Ratio

ASSYSTEM has a trailing twelve months price to earnings ratio of 8.1. Meaning, the purchaser of the share is investing €8.1 for every euro of annual earnings.

Volatility

ASSYSTEM’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.17%, a positive 0.11%, and a positive 1.35%.

ASSYSTEM’s highest amplitude of average volatility was 1.54% (last week), 1.16% (last month), and 1.35% (last quarter).

More news about ASSYSTEM.

9. GAMING INNOVATION (GIG.OL)

-6.12% Price Change

Gaming Innovation Group Inc., an iGaming technology company, together with its subsidiaries, provides solutions, products, and services to iGaming operators in Nordic countries, other European countries, and internationally. It operates through two segments, Platform Offering Front-End Services (Platform), and Affiliate Marketing (Media). The company operates casinos and sports betting sites; and platform services, including igaming platform solutions and services to operators and their customers, as well as undertakes land-based operators online through its omnichannel solution, which brings together the offline and online worlds through a shared loyalty system and wallets. It also provides Sportsbook, a sports betting omnichannel solution. In addition, the company offers managed service; omnichannel solutions; Data platform to enhance BI and make business decisions; Logic, a real-time rules engine that creates actionable business rules; marketing compliance solution; and Frontend solution. Gaming Innovation Group Inc. was founded in 2012 and is headquartered in St. Julian's, Malta.

Oslo Børs Benchmark Index_GI ended the session with GAMING INNOVATION falling 6.12% to €29.15 on Friday, after three successive sessions in a row of losses. Oslo Børs Benchmark Index_GI slid 0.61% to €1,391.56, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, GAMING INNOVATION has a trailing twelve months EPS of kr1.72.

PE Ratio

GAMING INNOVATION has a trailing twelve months price to earnings ratio of 16.95. Meaning, the purchaser of the share is investing kr16.95 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.95%.

More news about GAMING INNOVATION.

10. PETROLIA (PSE.OL)

-5.61% Price Change

Petrolia SE, together with its subsidiaries, sells and rents energy service equipment to energy industry in Norway, rest of Europe, Asia, and Australia. It operates in two segments, Energy and Energy Service. The company engages in the exploration and production of oil and gas, as well as production of hydrogen and ammonia. It also offers drill pipes, test strings and tubing, and other equipment, as well as casing, handling, and auxiliary tools; and equipment inspection and maintenance services. In addition, the company offers casing and tubing running, drilling, and make and brake services. It serves energy companies, drilling contractors, and energy service companies. The company was formerly known as Petrolia E&P Holdings SE and changed its name to Petrolia SE in January 2013. Petrolia SE was founded in 1997 and is based in Limassol, Cyprus.

Oslo Børs Benchmark Index_GI ended the session with PETROLIA falling 5.61% to €5.05 on Friday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI fell 0.61% to €1,391.56, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, PETROLIA has a trailing twelve months EPS of kr0.32.

PE Ratio

PETROLIA has a trailing twelve months price to earnings ratio of 15.78. Meaning, the purchaser of the share is investing kr15.78 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.43%.

More news about PETROLIA.

Stay up to date with our winners and losers daily report